Search - tctmd.com

Displaying 141 - 160 of 382

Sort: Relevancy | Date

Presentation NY Valves 2024

Outcomes in Patients With Severe Mitral Annular Calcifications and High-Risk for Left Ventricular Outflow Tract Obstruction Referred for Mitral Valve Therapies

Presenter: Gennaro Giustino

June 05, 2024

Presentation NY Valves 2024

Transparent and Robust Artificial Intelligence-Driven Electrocardiogram Model for Left Ventricular Systolic Dysfunction

Presenter: Hak Seung Lee

June 05, 2024

Presentation NY Valves 2024

Mitral PVL Closure in Prior Surgical Left Ventricular PSA: Closing the Gap and Filling the Hole

Presenter: Matteo Sturla

June 05, 2024

Presentation NY Valves 2024

Rescue Balloon Valvuloplasty to Resolve LVOT Obstruction During the TMVR With LAMPOON Procedure

Presenter: Ayush Goyal

June 05, 2024

Presentation NY Valves 2024

Prophylactic VA-ECMO for TAVI Using Self-Expandable Valves in Patients With Cardiogenic Shock and a Left Ventricular Ejection Fraction Below 30%

Presenter: Eduardo A. Arias

June 05, 2024

Presentation NY Valves 2024

TMVR in MAC Employing Antegrade Lampoon Technique, With Neo-LVOT 107mm3

Presenter: Praveen Chandra

June 05, 2024

Presentation NY Valves 2024

A Bit of Alcohol Saved This Patient

Presenter: Vikrant Jagadeesan

June 05, 2024

Presentation NY Valves 2024

LVOTO Provocation During Mitral-TEER for Dynamic LVOTO: Poking the Bear

Presenter: Matteo Sturla

June 05, 2024

Presentation THT Abstracts 2024

Appreciating the immediate changes in left ventricular cardiomechanics after transcatheter aortic valve replacement for moderate aortic stenosis: a case series

Presenter: Antoon van den Enden

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Presenter: Eduardo Arias

March 05, 2024

Presentation THT Abstracts 2024

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Presenter: Jennifer Cowger

March 05, 2024

Presentation THT Abstracts 2024

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Presenter: John Eisenga

March 05, 2024

Presentation THT 2024

In-vivo Pressure-Volume Reconstructions to Evaluate Immediate Changes in Left Ventricular Cardiomechanics Following Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis

Presenter: Antoon van den Enden

March 05, 2024

Presentation THT 2024

Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study

Presenter: Palak Shah

March 05, 2024

Presentation THT 2024

Initial Experience with Transcatheter Myotomy (SESAME) to Treat Hypertrophic Cardiomyopathy and Left Ventricular Outflow Obstruction

Presenter: Adam B. Greenbaum

March 05, 2024

Presentation THT 2024

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Presenter: Mary Quien

March 05, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Presentation THT Abstracts 2024

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach †

Presenter: Kyung-Hee Kim

March 04, 2024

Advertisement

Outcomes in Patients With Severe Mitral Annular Calcifications and High-Risk for Left Ventricular Outflow Tract Obstruction Referred for Mitral Valve Therapies

Transparent and Robust Artificial Intelligence-Driven Electrocardiogram Model for Left Ventricular Systolic Dysfunction

Mitral PVL Closure in Prior Surgical Left Ventricular PSA: Closing the Gap and Filling the Hole

Rescue Balloon Valvuloplasty to Resolve LVOT Obstruction During the TMVR With LAMPOON Procedure

Prophylactic VA-ECMO for TAVI Using Self-Expandable Valves in Patients With Cardiogenic Shock and a Left Ventricular Ejection Fraction Below 30%

TMVR in MAC Employing Antegrade Lampoon Technique, With Neo-LVOT 107mm3

A Bit of Alcohol Saved This Patient

LVOTO Provocation During Mitral-TEER for Dynamic LVOTO: Poking the Bear

Appreciating the immediate changes in left ventricular cardiomechanics after transcatheter aortic valve replacement for moderate aortic stenosis: a case series

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

In-vivo Pressure-Volume Reconstructions to Evaluate Immediate Changes in Left Ventricular Cardiomechanics Following Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis

Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study

Initial Experience with Transcatheter Myotomy (SESAME) to Treat Hypertrophic Cardiomyopathy and Left Ventricular Outflow Obstruction

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach †

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content